


TAVR (Transcatheter Aortic Valve Replacement) Success Rate in New Delhi
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
TAVR Success Rate: Understanding Outcomes in New Delhi
Understanding the potential success rate of TAVR (Transcatheter Aortic Valve Replacement) is crucial for patients considering this advanced cardiac procedure. Outcomes depend significantly on individual patient health, the severity of aortic stenosis, and associated comorbidities. New Delhi stands as a key medical destination where TAVR procedures are performed, with data carefully reviewed across various healthcare settings.
The aggregated clinical data and treatment-level evaluations in New Delhi reflect outcomes comparable to international standards. Success rates for TAVR are continually assessed, considering diverse methodologies and patient profiles. It is vital for patients to understand that specific outcomes vary by individual case, a factor carefully considered by medical professionals here.
What "Success" Signifies for TAVR Patients
For Transcatheter Aortic Valve Replacement (TAVR), "success" encompasses several key indicators beyond just procedural completion. It often means significant improvement in cardiac function, reduction of severe symptoms like shortness of breath and chest pain, and enhanced quality of life. Success also considers the absence of major complications, improved mobility, and the duration of these benefits, differentiating between short-term post-procedure stability and long-term functional recovery.
TAVR Success Rate Breakdown in New Delhi
Success rates vary depending on treatment approach and patient factors.
| Outcome Metric / Category | Typical Focus Area | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Procedural Success | Immediate outcome of valve deployment | Varies significantly by patient profile and clinical context | Successful valve implantation without major complications (e.g., severe paravalvular leak) |
| 30-Day TAVR Survival Rate | Short-term post-procedure mortality | Varies significantly by patient profile and clinical context | Patient survival within one month following the TAVR procedure, reflecting acute safety |
| 1-Year TAVR Survival Rate | Mid-term mortality and stability | Varies significantly by patient profile and clinical context | Patient survival one year after TAVR, indicating durable early-to-mid-term benefit |
| Symptomatic Improvement | Quality of life and functional recovery | Varies significantly by patient profile and clinical context | Reduction in heart failure symptoms and improvement in physical activity levels |
TAVR Survival Rate by Age and Comorbidity in New Delhi
The TAVR survival rate by age in New Delhi, much like global trends, shows variations tied closely to a patient's age and overall health status. Older patients with multiple underlying health conditions typically present with different outcome profiles compared to younger, healthier individuals. Stage wise TAVR survival rate in New Delhi also accounts for the severity of aortic stenosis and the presence of other significant heart or systemic diseases at the time of the procedure. These outcome trends align with internationally observed clinical practices and data.
| Age Group / Patient Category | Key Influencing Factors | Success Rate Range (%) |
|---|---|---|
| Younger Patients (e.g., under 70) | Typically fewer comorbidities, robust physiology | Varies significantly by patient profile and clinical context |
| Elderly Patients (e.g., 70-85 years) | Higher likelihood of comorbidities, moderate frailty | Varies significantly by patient profile and clinical context |
| Very Elderly Patients (e.g., over 85) | Significant comorbidities, increased frailty index | Varies significantly by patient profile and clinical context |
| High Surgical Risk Patients | Multiple severe comorbidities precluding open-heart surgery | Varies significantly by patient profile and clinical context |
| Intermediate/Low Surgical Risk Patients | Fewer or less severe comorbidities, better overall health | Varies significantly by patient profile and clinical context |
Comparing TAVR Success Rates: New Delhi vs. Global Trends
Success rates for TAVR in New Delhi are demonstrably comparable with international standards when similar protocols, cutting-edge technology, and careful patient selection are applied. Indian medical institutions increasingly participate in global clinical trials and adopt best practices, contributing to outcomes that align closely with leading cardiac centers worldwide. This reflects a commitment to high-quality patient care.
| Country/Region | TAVR Success Rate Range (%) |
|---|---|
| India (New Delhi) | Varies significantly by patient profile and clinical context |
| United States | Varies significantly by patient profile and clinical context |
| Germany | Varies significantly by patient profile and clinical context |
| United Kingdom | Varies significantly by patient profile and clinical context |
| Canada | Varies significantly by patient profile and clinical context |
| Australia | Varies significantly by patient profile and clinical context |
| Singapore | Varies significantly by patient profile and clinical context |
It is important to understand that TAVR success rates are indicative and never guaranteed. Outcomes vary due to individual patient conditions and the specific treatment approach utilized.
Factors Influencing TAVR Outcomes in New Delhi
The TAVR recovery rate in New Delhi is influenced by numerous patient-specific and procedural factors. These elements collectively determine the likelihood of a positive outcome and how well a patient recovers following the procedure. Understanding these can help set realistic expectations for the TAVR success rate in New Delhi.
- Severity of Aortic Stenosis: More advanced disease might present greater challenges.
- Patient Age and General Health: Younger, healthier patients typically experience better outcomes.
- Presence of Comorbidities: Conditions like kidney disease, lung disease, or other heart conditions can impact recovery.
- Heart Function Prior to TAVR: The strength of the heart muscle before the procedure is a significant predictor.
- Frailty Status: A patient's overall physical resilience and ability to recover from stress.
- Experience of the Medical Team: The expertise and volume of TAVR procedures performed by the center.
- Post-Procedure Care and Rehabilitation: Adherence to recovery protocols affects long-term success.
Data Sources and Methodologies for TAVR Outcomes
Reliable assessment of the TAVR success rate in New Delhi draws upon robust data collection and analysis. Leading centers such as AIIMS, Max Healthcare, and Fortis Healthcare, alongside other major institutes, follow evidence-based protocols that contribute to these outcomes. This commitment to data integrity provides a comprehensive understanding of procedural efficacy and long-term patient well-being.
- National and International Cardiovascular Registries that track TAVR patient outcomes.
- Peer-reviewed medical studies and clinical trials published in reputable journals.
- Aggregated multi-hospital outcome data, ensuring a broad and representative understanding.
- Longitudinal follow-up studies that monitor patients for extended periods post-procedure.
- Ethical institutional review board-approved clinical data collection processes.
Informed TAVR Decisions
Navigating treatment options requires clear, factual information. Understanding TAVR outcomes based on data supports confident, personalized healthcare decisions. This knowledge empowers patients to discuss their unique situation effectively with their medical team.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.

Artemis Hospital
Sector 51, Gurugram, Haryana, India

Lokmanya Hospitals
Not Specified

White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India

Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists




Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India





Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India

How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.